DEF 14A: Movano Inc. Seeks Stockholder Approval for Share Increase, Reverse Stock Split, and Incentive Plan Amendment

Movano Inc. is asking stockholders to approve proposals including increasing authorized shares, a reverse stock split, and amending the 2019 Omnibus Incentive Plan at its upcoming annual meeting.

Summary

• Movano Inc. has scheduled its annual meeting of stockholders for July 9, 2024, to be held virtually.
• The meeting will address several key proposals, including the election of a Class III director, an increase in the number of authorized shares of common stock from 150,000,000 to 500,000,000, and a reverse stock split at a ratio between 1-for-2 and 1-for-30.
• Additionally, stockholders will vote on an amendment to the 2019 Omnibus Incentive Plan to increase the number of shares reserved for issuance by 10,000,000, and the ratification of Moss Adams LLP as the independent registered public accounting firm for 2024.
• The Board of Directors recommends voting in favor of all proposals.
• The record date for determining stockholders eligible to vote is May 16, 2024, with 98,265,068 shares of common stock outstanding and entitled to vote as of that date.

Sentiment

Score: 6

Explanation: The document is neutral in tone, presenting necessary corporate actions. While the reverse stock split indicates past challenges, the proposals aim to improve the company's position.

Positives

• The proposed increase in authorized shares provides flexibility for future corporate purposes, including equity transactions and raising additional capital.
• The reverse stock split aims to increase the stock price to meet Nasdaq's minimum bid price requirement, potentially attracting new investors and improving liquidity.
• Amending the Omnibus Incentive Plan allows the company to attract and retain key personnel through competitive equity compensation.
• The virtual meeting format expands access and reduces costs for stockholders.

Negatives

• The reverse stock split may not increase the stock price long-term and could decrease liquidity.
• There is a risk of stockholders owning odd lots after the reverse stock split, leading to higher transaction costs.
• The reverse stock split could lead to a decrease in the company's overall market capitalization if the stock price does not increase proportionally.
• Failure to approve the share increase could severely harm the company's business and prospects.

Risks

• The reverse stock split may not achieve the desired increase in stock price to maintain Nasdaq listing compliance.
• Market conditions and company performance could negatively impact the stock price, regardless of the reverse stock split.
• The company's inability to raise capital through equity transactions if the share increase is not approved.
• Potential negative market perception of the reverse stock split, leading to decreased market capitalization.

Future Outlook

The company aims to use the increased authorized shares for potential future corporate purposes, including equity transactions to raise additional capital. The reverse stock split is intended to maintain Nasdaq listing compliance and attract new investors. The amended Omnibus Incentive Plan will help attract and retain key personnel.

Management Comments

• John Mastrototaro, Chief Executive Officer, cordially invites stockholders to attend the annual meeting.
• The Board believes that having an independent chairperson ensures that management is subject to independent and objective oversight.

Industry Context

The company's actions reflect a common strategy among companies facing Nasdaq listing compliance issues, where a reverse stock split is often employed to increase the stock price. Amending the Omnibus Incentive Plan is a standard practice to ensure competitive compensation packages in the technology and medical device industries.

Comparison to Industry Standards

• Reverse stock splits are a common tactic for companies facing delisting from exchanges like Nasdaq, similar to actions taken by companies such as Citius Pharmaceuticals and Farmmi, Inc. in recent years.
• Increasing authorized shares is a standard corporate practice to provide flexibility for future financing and strategic initiatives, comparable to moves by companies like Tesla and Apple when they needed capital for expansion.
• Equity compensation plans are a standard tool in the technology and medical device industries to attract and retain talent, similar to plans offered by companies like Medtronic and Resonant Inc.

Related Party Transactions

• Certain directors and executive officers participated in the January 2023 Offering, June 2023 Offering, November 2023 Offering and April 2024 Private Placement.

Stakeholder Impact

• Stockholders may experience changes in share value and liquidity due to the reverse stock split.
• Employees may benefit from the amended Omnibus Incentive Plan through equity compensation.
• The company's ability to raise capital could impact its operations and future prospects, affecting all stakeholders.

Next Steps

• Stockholders to vote on the proposals at the Annual Meeting on July 9, 2024.
• Board to determine the specific ratio for the reverse stock split, if approved.
• Company to file the Certificate of Amendment with the Secretary of State of Delaware, if the proposals are approved.

Key Dates

Keywords

reverse stock split, authorized shares, proxy statement, annual meeting, Movano Inc., stockholders, incentive plan, directors, election, Nasdaq